isradipine has been researched along with Liver Diseases in 2 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Liver Diseases: Pathological processes of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Isradipine was simultaneously given orally (12C 5 mg) and i." | 1.28 | Pharmacokinetics of isradipine in patients with chronic liver disease. ( Cotting, J; Kutz, K; Laplanche, R; Nüesch, E; Reichen, J, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cotting, J | 1 |
| Reichen, J | 1 |
| Kutz, K | 1 |
| Laplanche, R | 1 |
| Nüesch, E | 1 |
| Pinquier, JL | 1 |
| Urien, S | 1 |
| Chaumet-Riffaud, P | 1 |
| Tillement, JP | 1 |
2 other studies available for isradipine and Liver Diseases
| Article | Year |
|---|---|
Pharmacokinetics of isradipine in patients with chronic liver disease.
Topics: Administration, Oral; Adult; Aminopyrine; Bile Acids and Salts; Biotransformation; Chronic Disease; | 1990 |
Differences in the serum binding determinants of isradipine and darodipine--consequences for serum protein binding in various diseases.
Topics: Adult; Blood Proteins; Calcium Channel Blockers; Fatty Acids, Nonesterified; Female; Humans; Hydroge | 1989 |